Literature DB >> 23059786

HIF-1α downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation.

M He1, Q-Y Wang, Q-Q Yin, J Tang, Y Lu, C-X Zhou, C-W Duan, D-L Hong, T Tanaka, G-Q Chen, Q Zhao.   

Abstract

Hypoxia-inducible factor 1 (HIF-1) is a crucial transcription factor for the cellular adaptive response to hypoxia, which contributes to multiple events in cancer biology. MicroRNAs (miRNAs) are involved in almost all cellular activities such as differentiation, proliferation, and apoptosis. In this work, we use miRNA microarrays to profile miRNA expression in acute myeloid leukemia (AML) cells with inducible HIF-1α expression, and identify 19 differentially expressed miRNAs. Our study shows that HIF-1α represses the expression of miR-17 and miR-20a by downregulating c-Myc expression. These two miRNAs alleviate hypoxia and HIF-1α-induced differentiation of AML cells. More intriguingly, miR-17 and miR-20a directly inhibit the p21 and STAT3 (signal transducer and activator of transcription 3) expression, both of which can reverse miR-17/miR-20a-mediated abrogation of HIF-1α-induced differentiation. Moreover, we show in vivo that miR-20a contributes to HIF-1α-induced differentiation of leukemic cells. Taken together, our results suggest that HIF-1α regulates the miRNA network to interfere with AML cell differentiation, representing a novel molecular mechanism for HIF-1-mediated anti-leukemic action.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23059786      PMCID: PMC3569981          DOI: 10.1038/cdd.2012.130

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  40 in total

1.  Effects of Tiron, 4,5-dihydroxy-1,3-benzene disulfonic acid, on human promyelotic HL-60 leukemia cell differentiation and death.

Authors:  Jin Sik Kim; Eun Wie Cho; Hai Won Chung; In Gyu Kim
Journal:  Toxicology       Date:  2006-03-22       Impact factor: 4.221

2.  Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors.

Authors:  Keith Woods; J Michael Thomson; Scott M Hammond
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

3.  A microRNA signature of hypoxia.

Authors:  Ritu Kulshreshtha; Manuela Ferracin; Sylwia E Wojcik; Ramiro Garzon; Hansjuerg Alder; Francisco J Agosto-Perez; Ramana Davuluri; Chang-Gong Liu; Carlo M Croce; Massimo Negrini; George A Calin; Mircea Ivan
Journal:  Mol Cell Biol       Date:  2006-12-28       Impact factor: 4.272

4.  Induction of tumor arrest and differentiation with prolonged survival by intermittent hypoxia in a mouse model of acute myeloid leukemia.

Authors:  Wei Liu; Meng Guo; Ya-Bei Xu; Dao Li; Zhao-Nian Zhou; Ying-Li Wu; Zhu Chen; Scott C Kogan; Guo-Qiang Chen
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

5.  A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.

Authors:  Yoji Hayashita; Hirotaka Osada; Yoshio Tatematsu; Hideki Yamada; Kiyoshi Yanagisawa; Shuta Tomida; Yasushi Yatabe; Katsunobu Kawahara; Yoshitaka Sekido; Takashi Takahashi
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

6.  c-Myc-regulated microRNAs modulate E2F1 expression.

Authors:  Kathryn A O'Donnell; Erik A Wentzel; Karen I Zeller; Chi V Dang; Joshua T Mendell
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

Review 7.  The JAK-STAT signaling pathway: input and output integration.

Authors:  Peter J Murray
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

8.  Functional analyses of the TEL-ARNT fusion protein underscores a role for oxygen tension in hematopoietic cellular differentiation.

Authors:  F Nguyen-Khac; V Della Valle; R G Lopez; E Ravet; M Mauchauffé; A D Friedman; L E Huang; S Fichelson; J Ghysdael; O A Bernard
Journal:  Oncogene       Date:  2006-03-20       Impact factor: 9.867

9.  MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation.

Authors:  Laura Fontana; Elvira Pelosi; Paolo Greco; Serena Racanicchi; Ugo Testa; Francesca Liuzzi; Carlo M Croce; Ercole Brunetti; Francesco Grignani; Cesare Peschle
Journal:  Nat Cell Biol       Date:  2007-06-24       Impact factor: 28.824

10.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

View more
  47 in total

1.  The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.

Authors:  Wang-Yang Chen; Xiao-Juan Zhao; Zhi-Fu Yu; Fu-Lan Hu; Yu-Peng Liu; Bin-Bin Cui; Xin-Shu Dong; Ya-Shuang Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expression.

Authors:  Audrey N Jajosky; James E Coad; Jeffrey A Vos; Karen H Martin; Jamie R Senft; Sharon L Wenger; Laura F Gibson
Journal:  Stem Cells Transl Med       Date:  2014-05-22       Impact factor: 6.940

Review 3.  HypoxamiRs and cancer: from biology to targeted therapy.

Authors:  Harriet E Gee; Cristina Ivan; George A Calin; Mircea Ivan
Journal:  Antioxid Redox Signal       Date:  2013-11-22       Impact factor: 8.401

Review 4.  Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K.

Authors:  Rupert Courtnay; Darleen C Ngo; Neha Malik; Katherine Ververis; Stephanie M Tortorella; Tom C Karagiannis
Journal:  Mol Biol Rep       Date:  2015-04       Impact factor: 2.316

Review 5.  Reciprocal regulations between miRNAs and HIF-1α in human cancers.

Authors:  Wanli Yang; Jiaojiao Ma; Wei Zhou; Bo Cao; Xin Zhou; Hongwei Zhang; Qingchuan Zhao; Liu Hong; Daiming Fan
Journal:  Cell Mol Life Sci       Date:  2018-10-13       Impact factor: 9.261

6.  MiR-124 reversed the doxorubicin resistance of breast cancer stem cells through STAT3/HIF-1 signaling pathways.

Authors:  Cong Liu; Hua Xing; Caixia Guo; Zhaoying Yang; Yimin Wang; Yingying Wang
Journal:  Cell Cycle       Date:  2019-07-29       Impact factor: 4.534

Review 7.  The progress of angiogenic factors in the development of leukemias.

Authors:  Yang Han; Xidi Wang; Bingping Wang; Guosheng Jiang
Journal:  Intractable Rare Dis Res       Date:  2016-02

8.  MicroRNA-130a expression is decreased in Xinjiang Uygur patients with type 2 diabetes mellitus.

Authors:  Yi Jiao; Manli Zhu; Xinmin Mao; Mei Long; Xian Du; Yun Wu; Kelimu Abudureyimu; Cheng Zhang; Ye Wang; Yicun Tao; Xin Luo; Linlin Li
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

9.  Nickel-induced HIF-1α promotes growth arrest and senescence in normal human cells but lacks toxic effects in transformed cells.

Authors:  Michal W Luczak; Anatoly Zhitkovich
Journal:  Toxicol Appl Pharmacol       Date:  2017-05-25       Impact factor: 4.219

10.  Induction of microRNA-17-5p by p53 protects against renal ischemia-reperfusion injury by targeting death receptor 6.

Authors:  Jielu Hao; Qingqing Wei; Shuqin Mei; Lin Li; Yunchao Su; Changlin Mei; Zheng Dong
Journal:  Kidney Int       Date:  2016-09-09       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.